Clinical Significance
Anti-Müllerian Hormone Test (AMH) is a marker that is used to evaluate an ovarian reserve and predict the outcome of In-vitro Fertilization (IVF) or other Assisted Reproductive Technology (ART). This test can also be used to assess the ovarian function in patients with Polycystic Ovarian Syndrome (PCOS), to diagnose and monitor Ovarian tumors, and to determine the menopausal status.
[su_spoiler title=”Technique” open=”no” style=”default” icon=”plus” anchor=”” anchor_in_url=”no” class=””]
C.L.I.A
[/su_spoiler]
[su_spoiler title=”Who Prescribes” open=”no” style=”default” icon=”plus” anchor=”” anchor_in_url=”no” class=””]
General physician, General Medicine, endocrinologist
[/su_spoiler]
[su_spoiler title=”Reporting Tat” open=”no” style=”default” icon=”plus” anchor=”” anchor_in_url=”no” class=””]
12
[/su_spoiler]
[su_spoiler title=”Sample Type” open=”no” style=”default” icon=”plus” anchor=”” anchor_in_url=”no” class=””]
SERUM
[/su_spoiler]
[su_spoiler title=”Fasting” open=”no” style=”default” icon=”plus” anchor=”” anchor_in_url=”no” class=””]
N
[/su_spoiler]
Reviews
There are no reviews yet.